XBP Global vs Xometry
XBP and XMTR side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How XBP and XMTR compare
Xometry is the larger company, worth 230 times as much as XBP Global ($6.6B against $28.6M).
Xometry scores higher on the StockData Score (5 against 3 for XBP Global), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | XBP | XMTR |
|---|---|---|
| Size and price | ||
| Market cap | $28.6M | $6.6B |
| Share price | $2.41 | $114.95 |
| Change, 1 year | −64.4% | 89.7% |
| Change, 5 years | −97.6% | 128% |
| Beta (5Y) | 0.14 | 2.82 |
| Employees | 11K | 1,174 |
| StockData Score | ||
| Total score | 3 | 5 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 8.2× |
| P/B | 0.6× (better) | 11.1× |
| Fair value | $8.28 | $25.33 |
| Margin of safety | 70.9% (better) | −354% |
| Growth | ||
| Revenue growth (TTM) | – | 33.7% |
| Revenue growth, 5Y average | – | 37.2% |
| Profitability | ||
| Gross margin | – | 38.7% |
| Operating margin | – | −3.8% |
| Return on invested capital | – | −39.3% |
| Financial health | ||
| Debt / equity | 8.03 | – |
| Interest coverage | – | −6.1× |
| Current ratio | 0.64 | 3.21 (better) |
| Altman Z-score | −0.81 | 9.17 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 84.6% | 98.2% |
| Held by insiders | – | 8.8% |
| Insider net buying, 12 months | $2.5M (better) | −$20.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 7.1% |
Go deeper
- XBP stock overview
- XBP income statement
- XBP valuation and score
- XMTR stock overview
- XMTR income statement
- XMTR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.